Here We Go Again: US FDA Weighing Accelerated Approval For Biogen’s ALS Drug Tofersen

 
• By Sue Sutter
  
Opening the door
Tofersen could open the door to use of the accelerated approval pathway for other ALS treatments. • Source: Shutterstock

More from Approval Standards

More from Pathways & Standards